Augmentation cystoplasty: What are the indications?

Current Urology Reports

Volumn 9, Issue 6, 2008, Pages 452-458

  Reyblat, Polina ^b   Ginsberg, David A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; CAPSAICIN; RESINIFERATOXIN;

BLADDER CAPACITY; BLADDER COMPLIANCE; BLADDER CONTRACTION; BLADDER PERFORATION; BLADDER RECONSTRUCTION; BLADDER STONE; COLON; CYSTITIS; HUMAN; ILEUM; INTERSTITIAL CYSTITIS; IRRADIATION; KIDNEY FUNCTION; LAPAROSCOPIC SURGERY; MULTIPLE SCLEROSIS; MYELODYSPLASTIC SYNDROME; NEUROGENIC BLADDER; OVERACTIVE BLADDER; POSTOPERATIVE INFECTION; REOPERATION; REVIEW; SCHISTOSOMIASIS; SPINAL CORD INJURY; STOMACH; SURGICAL APPROACH; TREATMENT INDICATION; URINE INCONTINENCE;

HUMANS; URINARY BLADDER; URINARY BLADDER DISEASES; UROLOGIC SURGICAL PROCEDURES;

EID: 57749098504     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-008-0078-0     Document Type: Review

References (41)

1. Tizzoni F: Die weiderherstellung der harnblase. Zentralbl Chir 1888, 15:921-924.
2. Mikulicz JA: I. Zur Operation der angeborenen Blasenspalte. Centralbl Chir 1899, 26:641-643.
3. Lay EB: Bladder made from gallbladder. Arch Ital di Chir 1925, 11:333-335.
4. Wein AJ: Pathophysiology and classification of voiding dysfunction. In Campbell-Walsh Urology, edn 9. Edited by Wein AJ, Kavoussi LR, Novick AC, et al. Philadelphia: Elsevier; 2007:1973-1985.
5. Wines MP, Lynch WD: A new minimally invasive technique for treating radiation cystitis: the argon-beam coagulator. BJU Int 2006, 98:610-612.
6. Blaivas JG, Weiss JP, Desai P, et al.: Long-term followup of augmentation enterocystoplasty and continent diversion in patients with benign disease. J Urol 2005, 173:1631-1634. Contemporary review of outcomes, post-augmentation urodynamic parameters, and complications in a group with mixed bladder etiology.
7. Weld KJ, Dmochowski RR: Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury. Urol 2000, 55:490-494.
8. Bauer SB, Hallet M, Khoshbin S, et al.: The predictive value of urodynamic evaluation in the newborn with myelodysplasia. JAMA 1984; 152:650.
9. Gilbert SM, Hensle TW: Metabolic consequences and long-term complications of enterocystoplasty in children: a review. J Urol 2005, 173:1080-1086.
10. Atala A, Bauer SB, Soker S, et al.: Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006, 367:1241-1246. Landmark article describing use of tissue-engineered bladder.
11. Razdan S, Leboeuf L, Meinbach DS, et al.: Current practice patterns in the urologic surveillance and management of patients with spinal cord injury. Urol 2003, 61:893-896.
12. Dykstra DD, Sidi AA: Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Archives of Physical Medicine and Rehabilitation 1990, 71:24-26.
13. Schurch B, de Seze M, Denys P, et al.: Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 2005, 174:196-200. Randomized study of BTX-A use in the neurogenic bladder, demonstrating significant improvement in the study group.
14. Karsenty G, Reitz A, Lindemann G, et al.: Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity. Urol 2006, 68:1193-1197.
15. Akbar M, Abel R, Seyler TM, et al.: Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction. BJU Int 2007, 100:639-645.
16. de Seze M, Wiart L, de Seze MP, et al.: Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study. J Urol 2004, 171:251-255.
17. Quek ML, Ginsberg DA: Long-term urodynamics followup of bladder augmentation for neurogenic bladder. J Urol 2003, 169:195-198.
18. Khastgir J, Hamid R, Arya M, et al.: Surgical and patient reported outcomes of "clam" augmentation ileocystoplasty in spinal cord injured patients. Eur Urol 2003, 43:263-269.
19. Turabelidze G, Schootman M, Zhu BP, et al.: Multiple sclerosis prevalence and possible lead exposure. J Neurol Sci 2008, 269:158-162.
20. Litwiller SE, Frohman EM, Zimmern PE: Multiple sclerosis and the urologist. J Urol 1999, 61:743-757.
21. Wyndaele JJ, Castro D, Madersbacher H, et al.: Neurogenic and faecal incontinence. In Incontinence. Edited by Abrams P, Cardozo L, Khoury S, Wein A. Paris: Health Publications; 2005:1059-1162.
22. Sirls LT, Zimmern PE, Leach GE: Role of limited evaluation and aggressive medical management in multiple sclerosis: a review of 113 patients. J Urol 1994, 151:946-950.
23. Zommick JN, Simoneau AR, Skinner DG, Ginsberg DA: Continent lower urinary tract reconstruction in the cervical spinal cord injured population. J Urol 2003, 169:2184-2187.
24. Nielsen KK, Kromann-Andersen B, Steven K, et al.: Failure of combined supratrigonal cystectomy and Mainz ileocecocystoplasty in intractable interstitial cystitis: is histology and mast cell count a reliable predictor for the outcome of surgery? J Urol 1990, 144:255-258.
25. van Ophoven A, Oberpenning F, Hertle L: Long-term results of trigone-preserving orthotopic substitution enterocystoplasty for interstitial cystitis. J Urol 2002, 167:603-607.
26. Kisman OK, Lycklama à Nijeholt AA, van Krieken JH: Mast cell infiltration in intestine used for bladder augmentation in interstitial cystitis. J Urol 1991, 146:1113-1114.
27. Parsons CL, Bautista SL, Stein PC, et al.: Cyto-injury factors in urine: a possible mechanism for the development of interstitial cystitis. J Urol 2000, 164:1381-1384.
28. Abrams P: Describing bladder storage function: overactive bladder syndrome and detrusor overactivity. Urol 2003, 62:28-37.
29. Westney OL, Lee JT, McGuire EJ, et al.: Long-term results of Ingelman-Sundberg denervation procedure for urge incontinence refractory to medical therapy. J Urol 2002, 168:1044-1047.
30. Weil EH, Ruiz-Cerda JL, Eerdmans PH, et al.: Sacral root neuromodulation in the treatment of refractory urinary urge incontinence a prospective randomized clinical trial. Eur Urol 2000, 37:161-171.
31. Sahai A, Khan MS, Dasgupta P: Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. J Urol 2007, 177:2231-2236. Another randomized placebo-controlled study demonstrating efficacy of botulinum toxin-A. This study looked at patients without neurologic diagnosis, broadening the potential uses of botulinum toxin-A.
32. Awad SA, Al-Zahrani HM, Gajewski JB, Bourque-Kehoe AA: Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women. Br J Urol 1998, 81:569-573.
33. Pope JC, Keating MA, Casale AJ, Rink RC: Augmenting the augmented bladder: treatment of the contractile bladder segment. J Urol 1998, 160:854-857.
34. Hafez AT, McLorie G, Gilday D, et al.: Long-term evaluation of metabolic profile and bone mineral density after ileocystoplasty in children. J Urol 2003, 170:1639-1641.
35. Nurse DE, Mundy AR: Metabolic complications of cystoplasty. Br J Urol 1989, 63:165-170.
36. Plaire J, Snodgrass WT, Grady RW, Mitchell ME: Long-term followup of the hematuria-dysuria syndrome. J Urol 2000, 164:921-923.
37. DeFoor W, Minevich E, Reeves D, et al.: Gastrocystoplasty: long-term followup. J Urol 2003, 170:1647-1649.
38. Albo ME, Raz S, Dupont MC: Anterior flap extraperitoneal cystoplasty. J Urol 1997, 157:2095-2098.
39. Gill IS, Rackley RR, Meraney AM, et al.: Laparoscopic enterocystoplasty. Urol 2000, 55:178-181.
40. Elliot SP, Meng MV, Anwar HP, Stoller ML: Complete laparoscopic ileal cystoplasty. Urol 2002, 59:939-943.
41. Shpall AI, Ginsberg DA: Bladder neck closure with lower urinary tract reconstruction: technique and long-term followup. J Urol 2004, 172:2296-2299.